Derma Sciences
Randi Rutan is currently the Director of Clinical Development in Regenerative Medicine at Mallinckrodt Pharmaceuticals since March 2019. Prior to this role, Randi served as the Vice President of Medical Affairs at DermaSciences starting in July 2013. With a background in nursing, Randi has held positions such as Director of Clinical Operations at LifeCell from 2005 to 2012 and Clinical Manager at Ethicon from 2001 to 2005. Randi obtained a Bachelor's degree in Nursing from The University of Texas Medical Branch in 1984.
Derma Sciences
Derma Sciences is a Medical Devices company specializing in the field of Advanced Wound Care. Currently their major products are Medihoney, Algicell AG, Xtrasorb wound dressing, Bioguard and Mobility1. Their newest product DSC127 - an Angiotensin Analog - is currently in Phase II Pre-Clinical trials.